Health
Moffitt researchers reveal why some ovarian cancer patients evolve better than others – News-Medical.Net
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed….
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed. These poor outcomes are partly due to the lack of effective therapies for advanced disease and recurrence. Immunotherapies hold promise for many types of cancer; however, studies have shown that patients with ovarian cancer do not have strong responses to existing drugs.
In a new article published in Nature, Moffitt Cancer Center…
-
Noosa News20 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business21 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News23 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Noosa News19 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix